Truss has modified its software to advance communications while hospitals are cracking down on visitors amid the coronavirus outbreak. Getty Images

With hospitals cracking down on people allowed into patient rooms, a Houston startup has adjusted its software to provide a solution to communications issues between patients, doctors, and family members.

Houston-based Truss usually focuses on digital community engagement, but Patrick Schneidau, CEO of the company, says he felt called to do something to help families separated due to strict emergency visitation rules at hospitals.

"You read all the stories of loved ones not being able to be together during this time," Schneidau says. "That was the area we wanted to focus on."

Schneidau describes the software as a secure portal for small groups to interact via smart devices. Physicians can interface with family members via video chat or recorded messages, as well as answer any questions.

"We've done some preliminary research — doctors themselves want to communicate with the family," Schneidau says, "but they can't be on six different phone calls throughout the day for one patient."

So as not to burden hospital staff unnecessarily, the platform would also provide answers to common questions and resources. Perhaps most importantly, the software can allow patients to interact with their family members from afar.

According to Schneidau, Truss is seeking hospitals that might be interested in the technology and recognizes that hospitals are currently jumping on new tech opportunities in this time of crisis, like Houston Methodist, which is equipping its hospital rooms with tablets.

"We've talked to a number of hospitals, and every one is facing this issue," Schneidau says. "We're figuring out who would be the right people to participate in the tool itself."

Beyond the COVID-19 pandemic, Schneidau, who's a member if InnovationMap's board of directors, says he thinks the platform could be helpful communications in nursing homes.

"The outside forces being what they are and preventing visitors in the room doesn't preclude the need to communicate with family members," says Schneidau. "So you have to come up with an innovative solution very quickly to be able to address that particular issue. This is a possible answer to that."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.